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Abstract
Upon reactivation from latency and during lytic infections in neurons, alphaherpesviruses
assemble cytosolic capsids, capsids associated with enveloping membranes, and transport
vesicles harboring fully enveloped capsids. It is debated whether capsid envelopment of
herpes simplex virus (HSV) is completed in the soma prior to axonal targeting or later, and
whether the mechanisms are the same in neurons derived from embryos or from adult
hosts. We used HSV mutants impaired in capsid envelopment to test whether the inner teg-
ument proteins pUL36 or pUL37 necessary for microtubule-mediated capsid transport were
sufficient for axonal capsid targeting in neurons derived from the dorsal root ganglia of adult
mice. Such neurons were infected with HSV1-ΔUL20 whose capsids recruited pUL36 and
pUL37, with HSV1-ΔUL37 whose capsids associate only with pUL36, or with HSV1-ΔUL36
that assembles capsids lacking both proteins. While capsids of HSV1-ΔUL20 were actively
transported along microtubules in epithelial cells and in the somata of neurons, those of
HSV1-ΔUL36 and -ΔUL37 could only diffuse in the cytoplasm. Employing a novel image
analysis algorithm to quantify capsid targeting to axons, we show that only a few capsids of
HSV1-ΔUL20 entered axons, while vesicles transporting gD utilized axonal transport effi-
ciently and independently of pUL36, pUL37, or pUL20. Our data indicate that capsid motility
in the somata of neurons mediated by pUL36 and pUL37 does not suffice for targeting cap-
sids to axons, and suggest that capsid envelopment needs to be completed in the soma
prior to targeting of herpes simplex virus to the axons, and to spreading from neurons to
neighboring cells.
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Author summary
Human and animal alphaherpesviruses establish lifelong latent infections in neurons of
the peripheral nervous system and cause many diseases upon primary infection as well as
following reactivation from latency. The highly prevalent human herpes simplex viruses
HSV-1 and HSV-2 are responsible for facial and genital herpes, potentially blinding eye
infections, and life-threatening encephalitis and meningitis. Here, we asked how these
viruses master the bottleneck of being targeted from the neuronal somata to the axons.
Our data suggest that only transport vesicles harboring fully matured virus particles can
enter axons for spreading infection to the brain or the peripheral organs. Our data imply
that the limiting membrane of the transport vesicles must expose viral or host receptors to
recruit the microtubule motors required for axonal transport. Inhibiting such viral factors
on the surface of the transport vesicles might provide novel therapeutic approaches to pre-
vent the spread of alphaherpesviruses in the nervous system.
Introduction
Many pathogens spread within the nervous system by fast intracellular axonal transport medi-
ated by microtubule motors, and progeny particles are transmitted via synapses from neuron
to neuron [1,2]. Such life style allows pathogens to hide from the extracellular complement sys-
tem, from antibodies, and from immune cells. But it comes with the challenge of finding the
tiny exit gates from the neuronal somata, and of specific targeting to dendrites or to axons. It
has been estimated that the cross section of the axonal outlet occupies less than 2 thousandth
of the surface area of the soma [3,4]. The molecular post codes achieving this remarkable intra-
cellular trafficking control are not well understood; neither for host nor for pathogen cargoes.
Alphaherpesviruses such as herpes simplex viruses (HSV) replicate in the skin, the eyes,
and the oral, genital, or nasal mucosa, and then enter local axon endings of sensory or auto-
nomic neurons in which they establish latency with little gene expression. Latent HSV-1
genomes have been detected in human cranial ganglia, especially in the trigeminal ganglia,
while dorsal root ganglia (DRG) can harbor both, HSV-1 and HSV-2 [5–7]. Viral gene expres-
sion can be reactivated upon stress and a decline in the local immune responses, and progeny
viruses are transported back to the periphery, where they cause lytic infections. Efficient target-
ing of alphaherpesviruses to the axons is essential for axonal spread and thus disease. Severe
outcomes are potentially blinding herpes keratitis upon spread within the eyes or life-threaten-
ing herpes encephalitis upon spread within the brain [reviewed in 8,9].
The HSV-1 virion contains a large double-stranded DNA genome encased in a viral capsid,
numerous tegument proteins and an envelope with many viral membrane proteins. Further-
more several host proteins and mRNAs have been detected in highly purified inocula [10–12].
HSV-1 assembly begins in the nucleus with genome packaging into capsids, which then tra-
verse the nuclear envelope [reviewed in 13,14]. Cytosolic capsids associate with the inner
tegument proteins pUL36 and pUL37 for their intracellular transport along microtubules to
cytoplasmic membranes, where they meet other tegument and viral membrane proteins for
secondary envelopment and virion formation [15–24]. In addition to pUL36 and pUL37,
other structural proteins are required for efficient capsid envelopment. HSV-1 mutants
lacking either pUL36 or pUL37, or the membrane proteins pUL20 or glycoprotein K (gK) are
severely impaired in cytoplasmic envelopment, and accumulate cytosolic capsids instead
[15,16,18,20,25–32]. HSV1-pUL20 and gK form functional complexes that connect with the
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capsids via pUL37 which in turn binds to pUL36 and the small capsid protein VP26 [33–36].
Another prominent tegument linker is VP16, with binding sites for pUL36, VP11/12, VP22
and gH [22,34,37–39]. VP22 in turn can bind ICP0, pUL16, gD, gE and gM [reviewed in
21,22]. The resulting vesicles are transported to the cell periphery and fuse with the plasma
membrane to release infectious virions [reviewed in 13,14,22].
HSV-1 cytosolic capsids and complete virions within transport vesicles are targeted from
the neuronal somata to axons to a varying extent; this has led to different hypotheses on the
mode of neuronal alphaherpesvirus assembly [reviewed in 23,40,41]. According to the married
model, capsid envelopment occurs exclusively in the soma, and only transport vesicles harbor-
ing complete virions enter axons. The separate model refers to different cargo structures being
targeted independently of each other to the axons; namely capsids with associated tegument
proteins as well as vesicles harboring viral envelope proteins and tegument proteins associated
to their cytosolic tails.
Many structural proteins contribute to the neuronal spread of alphaherpesviruses, but the
molecular determinants that are required for microtubule motor recruitment and for targeting
from the soma to the axon gate have not been fully dissected. Purified HSV-1 capsids with
inner tegument proteins can recruit the microtubule motors kinesin-1, kinesin-2, dynein and
its cofactor dynactin to their surface, are translocated along microtubules in vitro, and can
dock to nuclear pores [11,42–44]. pUL36 of HSV-1 and of the porcine pseudorabies virus
(PRV) harbor potential binding motives for kinesin-1 light chains, and PRV-pUL36 has been
shown to bind dynein and dynactin [45–47]. For these reasons and based on many additional
functional studies, pUL36 and pUL37 are considered the most likely candidates for microtu-
bule motor recruitment [reviewed in 23,45,46,48].
We therefore hypothesized that pUL36 and pUL37 might be sufficient for axonal capsid tar-
geting and axonal capsid transport. As capsid envelopment may be a fast process, and since
therefore the steady-state concentration of cytosolic capsids might be low, we used HSV-1
mutants to enrich for assembly intermediates. We infected neurons with HSV1-ΔUL20,
HSV1-ΔUL37 or HSV1-ΔUL36 that accumulated cytosolic capsids decorated with pUL36 and
pUL37, only with pUL36, or lacking both. Our previous data indicate that acquisition of both
pUL36 and pUL37 is essential to enable capsids to enlist microtubule transport in epithelial
cells [20]. However, while these inner tegument proteins enabled intracellular capsid motility
of HSV1-ΔUL20 in epithelial cells and the somata of DRG neurons, they did not suffice to tar-
get cytosolic capsids to the axons. Our data indicate that HSV-1 particles have to acquire addi-
tional tegument and envelope proteins, and suggest that cytoplasmic envelopment needs to be
completed prior to axonal transport which is in accordance with the married model for assem-
bly of alphaherpesviruses in neurons.
Results
HSV-1 infection of mature neurons from dorsal root ganglia of adult mice
To investigate HSV-1 axonal targeting, we cultured primary neurons derived from dissociated
DRG of adult mice until they had developed mature neurites. Within 3 to 5 days of culture in
vitro (div), the neurons expressed the axonal microtubule-associated protein tau (not shown),
phosphorylated neurofilament, un-phosphorylated neurofilament, and ankyrinG. In the
somata, there were short β-III-tubulin microtubules and careful analysis often revealed a peri-
nuclear microtubule-organizing center (S1Aii Fig, arrow), but individual microtubules could
not be discerned in the neurites (S1A Fig). There were less phosphorylated neurofilament H
and M in the somata than in the neurites (S1B Fig), while non-phosphorylated neurofilament
H epitopes were distributed more evenly (S1C Fig), as reported for rat nervous tissue [49].
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Likewise ankyrinG, another axonal marker was targeted to the neurites (S1D Fig). In situ,
peripheral sensory axons also contain ankyrinG along the entire axons up to the dermal-epi-
dermal junction [50].
To evaluate the microtubule polarity in these neurites, we transduced the neurons at 1 div
with a lentiviral vector expressing end-binding protein 3 (EB3), which associates with dynami-
cally growing microtubule plus-ends [51]. At 4 div, live-cell imaging as well as time-projections
showed that all EB3-GFP comets moved away from the soma, suggesting that most, if not all,
microtubule plus-ends faced towards the distal ends of the neurites (not shown). These results
indicate that the DRG neurons had regrown neurites with axonal features and with a unipolar
microtubule polarity. We have shown previously that such neurons are productively infected,
and that they transmit HSV-1 to co-cultured epithelial cells upon infection with the HSV1
(17+)Lox-Che (c.f. Table 1), which had been cloned into a bacterial artificial chromosome
(BAC), and which expresses mCherry as a reporter [52,53].
HSV-1 mutants lacking pUL36, pUL37, or pUL20 assemble different
cytosolic capsids
To generate cytosolic capsids with different tegument protein composition, and thus to
determine whether the requirements for intracellular capsid motility parallel those for axonal
targeting, we constructed HSV1(17+)Lox-CheVP26-ΔUL36 [20], -CheVP26-ΔUL37 [20],
and -CheVP26-ΔUL20 (this study) in the same genetic background (c.f. Table 1). We deleted
the ATG start codon and a second ATG, and inserted three stop codons into the UL20 gene,
since it includes the promotor of UL19 that codes for the major capsid protein VP5. Restric-
tion analyses of pHSV1(17+)Lox-ΔUL20 and -CheVP26-ΔUL20 indicated the addition of
mCherry to VP26 (AscI and BamHI, C in S2A Fig), and that a resistance gene inserted with
the UL20 mutations had been removed (XhoI, asterisks in S2A Fig). Further HindIII (S2A
Fig), EcoRI, or EcoRV digestions resulted in the expected fragment sizes (not shown). HSV1
(17+)Lox-ΔUL20 and -CheVP26-ΔUL20 were recovered by transfecting the corresponding
BACs into Flp-In-CV-1-cells that express pUL20 in trans [54]. Sequencing of the mutated
region confirmed the introduction of the intended changes (not shown). The lack of the
ATGs and the introduced stop codons prevented the expression of pUL20, whereas pUL37
expression was unchanged (S2B Fig). The intra- and extracellular titers of HSV1(17+)Lox-
ΔUL20 and -CheVP26-ΔUL20 were about 1,000-fold lower than their parental strains in
non-complementing Vero cells, but higher in a pUL20 complementing cell line (S2C and
S2D Fig). Similar results have been reported for HSV1-ΔUL20 mutants in other genetic
Table 1. HSV1(17+)Lox strains used in this study.
HSV1(17+)Lox Genotype Reference
-CheVP26 codons for aa1-7 of VP26 replaced with mCherry [20]
-ΔUL36 entire coding sequence of UL36 deleted, no pUL36 expression [20,47]
-ΔUL37 codons for aa1-1121 of UL37 replaced by FRT site, no pUL37 expression [20]
-ΔUL20 pUL20 start codon mutated and stop codons inserted, no pUL20
expression
this study
-CheVP26-
ΔUL36
codons for aa1-7 of VP26 replaced with mCherry,
entire coding sequence of UL36 deleted, no pUL36 expression
[20,47]
-CheVP26-
ΔUL37
codons for aa1-7 of VP26 replaced with mCherry,
codons for aa1-1121 of UL37 replaced by FRT site, no pUL37 expression
[20]
-CheVP26-
ΔUL20
codons for aa1-7 of VP26 replaced with mCherry,
pUL20 start codon mutated and stop codons inserted, no pUL20
expression
this study
https://doi.org/10.1371/journal.ppat.1006813.t001
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backgrounds [25,26,54–56]. There were little differences between the parental Lox and the
-CheVP26 strains, indicating that tagging VP26 with mCherry (Che) did not impair HSV-1
replication, as reported before [24,57].
Using conventional electron microscopy, we next analyzed virus morphogenesis. Upon
infection of Vero cells with HSV1(17+)Lox (Fig 1A) or -CheVP26 (not shown), viral particle
maturation proceeded as expected with the formation of nuclear capsids, the appearance of
cytosolic capsids, partially and completely enveloped cytoplasmic capsids, and extracellular
virions associated with the plasma membrane. With secondary envelopment, capsids acquired
an electron dense tegument layer, and the electron dense genomes were well preserved (Fig
1Ai and 1Aiii; asterisk). Therefore the morphology of capsids and tegument of virions inside
authentic transport vesicles was more similar to that of extracellular virions (Fig 1Aii; black
arrow) than to that of cytosolic capsids (Fig 2Aiii; white arrowhead) even if they were partially
enveloped (Fig 1Ai and 1Aiii, black arrowhead). Nuclear capsid egress of the mutants HSV1
(17+)Lox-ΔUL20 (Fig 1Bi and 1Bii) and -CheVP26-ΔUL20 (Fig 1Biii) was unaffected, resulting
in many cytosolic capsids, and several of them were closely associated with cytoplasmic mem-
branes (Fig 1Bi and 1Bii; black arrowhead). We detected neither capsids with the characteristic
morphology of completed secondary envelopment nor virions bound to the plasma membrane
in the absence of pUL20. Furthermore, in contrast to infection with HSV1(17+)Lox-ΔUL36 or
-ΔUL37 [20], we did not detect any cytoplasmic or extracellular L-particles, which are viral
envelopes with an electron dense tegument but lacking capsids [58–60].
Next, we analyzed DRG cultures infected with HSV1(17+)Lox-CheVP26, -CheVP26-
ΔUL36, -CheVP26-ΔUL37, -CheVP26-ΔUL20 (Fig 2) or their respective untagged strains (not
shown) by electron microscopy. Neurons identified by the characteristic morphology of their
nuclei and infected with the parental HSV-1 strains contained nuclear capsids, primary envel-
opment intermediates (Fig 2A, white star), cytosolic capsids (Fig 2A, white arrowhead), and
enveloped virions (Fig 2A, black star). Neurons infected with HSV1(17+)Lox-CheVP26-
ΔUL36 (Fig 2B), -CheVP26-ΔUL37 (Fig 2C), or -CheVP26-ΔUL20 (Fig 2D) contained non-
enveloped cytosolic capsids (Fig 2, white arrowhead), but did not reveal any extracellular viri-
ons bound to their plasma membranes. HSV1(17+)Lox-CheVP26-ΔUL20 infected neurons
contained in addition wrapping intermediates (Fig 2D, black arrowhead). A quantification of
the number of cytoplasmic HSV-1 assembly intermediates revealed that cells infected with
HSV1(17+)Lox-ΔUL20 or -CheVP26-ΔUL20 had a similar ratio of cytosolic capsids to mem-
brane-associated capsids as upon infection with the respective parental strains HSV1(17+)Lox
or -CheVP26 (Table 2).
To characterize the surface protein composition of the cytosolic capsids, Vero cells were
infected with HSV1(17+)Lox or -ΔUL20 for 16 h, fixed, and ultrathin cryosections were pre-
pared for quantitative immunoelectron microscopy. We have reported similar experiments for
-ΔUL36 and -ΔUL37 before [20], and show their results here again for a direct comparison
(Fig 3Ai and 3Aii). Cytosolic capsids of both, Lox [20] and -ΔUL20 were labeled with anti-
pUL36 (Fig 3Aiii) and anti-pUL37 (Fig 3Aiv). There were on average 2.2 gold particles per
capsid for HSV1(17+)Lox, 2 for -ΔUL37 and -ΔUL20, but only 0.5 for -ΔUL36 (Fig 3Bi) using
anti-pUL36 antibodies. Upon labeling with anti-pUL37, there were 1.7 or 1.5 gold particles per
capsid for HSV1(17+)Lox or -ΔUL20, but only 0.5 for -ΔUL36 and -ΔUL37 (Fig 3Bii). These
results indicate that cytoplasmic capsids of Lox-ΔUL20 had recruited pUL36 and pUL37 to a
similar extent as those of the parental HSV1(17+)Lox, while capsids of -ΔUL37 lacked pUL37
but still recruited pUL36, and capsids of -ΔUL36 lacked both, pUL36 and pUL37. Thus, the
HSV1(17+)Lox-ΔUL36, -ΔUL37, and -ΔUL20 as well as HSV1(17+)Lox-CheVP26-ΔUL36,
-ΔUL37, and -ΔUL20 mutants generated cytosolic capsids exposing different proteins on their
surface, namely no inner tegument, only pUL36, or both pUL36 and pUL37.
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Fig 1. HSV1-pUL20 is required for secondary envelopment in epithelial cells. Vero cells infected with 1.9
x 106 pfu/mL (10 pfu/cell) of HSV1(17+)Lox (A), -ΔUL20 (Bi and Bii), or -CheVP26-ΔUL20 (Biii), fixed at 14 hpi,
and processed for conventional electron microscopy. Cytosolic capsids (white arrowheads), wrapping
Axonal targeting of HSV1 particles
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HSV-1-pUL20 is dispensable for capsid motility in epithelial cells and the
somata of neurons
To characterize the intracellular capsid motility in the presence of different inner tegument
proteins, we infected Vero cells with HSV1(17+)Lox-CheVP26, -CheVP26-ΔUL36, -CheVP26-
ΔUL37, or -CheVP26-ΔUL20 and acquired confocal fluorescence time-lapse movies with a
temporal resolution of 5 images per second. For a direct comparison, we analyzed in parallel
movies with -CheVP26 and -CheVP26-ΔUL20 recorded in this study as well as movies that we
had recorded with -CheVP26-ΔUL36 and -CheVP26-ΔUL37 previously and published in
Sandbaumhu¨ter et al. [20]. The time-projections of the tracks show that capsids of Lox-
CheVP26 (Fig 4Ai) and -CheVP26-ΔUL20 (Fig 4Aiv) exerted short and long range transport
towards the nucleus and towards the cell periphery (S1 and S4 Movies). In contrast, the tracks
of -CheVP26-ΔUL36 (Fig 4Aii) and -CheVP26-ΔUL37 (Fig 4Aiii) revealed only random, undi-
rected motility (S2 and S3 Movies).
While the average track length (Fig 4Bi) and the maximum step velocity (Fig 4Bii) were
similar for the capsids of -CheVP26, -CheVP26-ΔUL36, -CheVP26-ΔUL37, and -CheVP26-
ΔUL20, there were more tracks with a length of more than 5 μm and with a velocity exceeding
1 μm/s for the capsids of the parental Lox-CheVP26 and the -CheVP26-ΔUL20 than for the
capsids of -CheVP26-ΔUL36 and -CheVP26-ΔUL37. We furthermore determined the mean
square displacement exponent (MSDex) for each track (Fig 4Biii). The MSDex is a characteristic
feature for the displacement mode of a single motile particle from its starting position over
time. The MSD is defined as the square of the travelled distance from the starting point of the
track, which is calculated for each time point, and plotted against the time. The slope of such
a curve in a log-log plot defines the MSDex and indicates whether a particle has undergone
active transport (MSDex > 1), free diffusion (MSDex = 1), or confined diffusion [MSDex<1;
61,62,63]. While the MSDex of the majority of the tracks denoted free or confined diffusion as
expected for any intracellular cargo, the MSDex was greater than 1 for more tracks of Lox-
CheVP26 and -CheVP26-ΔUL20 than for -CheVP26-ΔUL36 or -CheVP26-ΔUL37.
We furthermore infected DRG neurons with HSV1(17+)Lox-CheVP26, -CheVP26-ΔUL36,
-CheVP26-ΔUL37, or -CheVP26-ΔUL20 and acquired spinning disk microscopy time lapse
movies of the cell bodies with a temporal resolution of 20 images per second. Similar as in the
epithelial cells, capsids of the parental (Fig 5Ai; S5 Movie) and -CheVP26-ΔUL20 (Fig 5Aiv; S8
Movie) were transported over short and longer distances as indicated by the time projection
lines. In contrast, the capsids of -CheVP26-ΔUL36 (Fig 5Aii; S6 Movie) and -CheVP26-ΔUL37
(Fig 5Aiii, S7 Movie) only moved in an undirected fashion. Quantification revealed that the
transport characteristics in DRG neuronal cell bodies were the same as in epithelial cells
(Fig 5Bi to 5iii). Thus, the motility features of the cytosolic capsids of -CheVP26-ΔUL36 or
-CheVP26-ΔUL37 in epithelial cells and sensory neurons were indicative for intracellular
diffusion which is also the mode of motility in the absence of microtubules after nocodazole
treatment [62]. In contrast, the capsids of -CheVP26 and -CheVP26-ΔUL20 had transport
characteristics typical for directed, active microtubule-dependent transport.
HSV-1 axonal targeting in the absence of pUL36, pUL37, or pUL20
After we had characterized the intracellular motility of capsids in the presence of pUL36 and
pUL37 (-ΔUL20), of only pUL36 (-ΔUL37), or lacking both (-ΔUL36), we asked which capsid
intermediates with capsids being closely associated with cytoplasmic membranes (black arrowheads), virions
after complete secondary envelopment (asterisk), and extracellular virions (arrow). Scale bars are 200 nm.
https://doi.org/10.1371/journal.ppat.1006813.g001
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Fig 2. Cytosolic capsids accumulate in the absence of pUL36 or pUL37 and pUL20 is required for
secondary envelopment in neurons. DRG neurons infected with 1 x 107 pfu/mL of HSV1(17+)Lox-
CheVP26 (A), -ΔUL36 (B), -ΔUL37 (C), -ΔUL20 (D), fixed at 24 or 30 hpi and processed for conventional
electron microscopy. Nucleus (N), primary enveloped virions (white stars), cytosolic capsids (white
arrowheads), wrapping intermediates with capsids being closely associated with cytoplasmic membranes
(black arrowheads), virions after complete secondary envelopment (black star), and extracellular virions
(arrow). Scale bar is 500 nm.
https://doi.org/10.1371/journal.ppat.1006813.g002
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types could be targeted to the axonal outlet. We infected primary DRG neurons with HSV1
(17+)Lox, -ΔUL36, -ΔUL37, or ΔUL20 (Fig 6) or the respective HSV1(17+)Lox-CheVP26
strains (S3 Fig, Fig 7). At 24 to 26 hpi, the cells were fixed, permeabilized and labeled with anti-
bodies directed against the capsid protein VP26 (Fig 6i and 6iv panels, green in 6iii), and the
tegument proteins VP22 (Fig 6A–6D, ii and v panels, red in iii and vi), the tegument protein
VP13/14 (Fig 7, ii panels, green in iii), the envelope protein gD (Fig 6E–6H, ii and iv panels,
red iii and vi), the envelope protein gB (Fig 7, vi panels, green in viii), or the neuron specific
beta-3-tubulin (Fig 7vii). Representative images from at least 3 independent experiments for
the different strains are shown in Figs 6, S3 and 7.
After infection with HSV1(17+)Lox (Fig 6A and 6E) or HSV1(17+)Lox-CheVP26 (Figs S3A
and 7A), the nucleoplasm (Figs 6Ai, 6Ei and S3Ai), the cytoplasm (Figs 6Ai, 6Ei and S3Ai) and
the axons (Fig 6Aiv, 6Eiv and 7A) were filled with capsids; in the cytoplasm, the capsids were
often clustered. Infection with -ΔUL36 (Figs 6B, 6F, S3B and 7B) resulted in a dispersed and
more random distribution of capsids in the cytoplasm of the somata (S3B Fig), with fewer cap-
sids being targeted to the axons (Figs 6Biv, 6Fi, 6Fv and 7B). After infection with -ΔUL37 (Figs
6C, 6G, S3C and 7C), capsids clustered within the cytoplasm and the cell morphology was
often altered; again very few capsids had been targeted to the axons (Figs 6Civ, 6Giv, 7Ci and
7Cv). The stronger cytopathic effects as indicated by membrane blebbing upon infection upon
infection with the HSV1-ΔUL37 strains (S3C Fig) might be due to the lack of pUL37 targeting
RIG-I and blocking RNA-induced activation [64], but we did not investigate this further.
Unexpectedly, there were also only very few axonal capsids upon infection with -ΔUL20
(Figs 6Hiv and 7D). The capsid distribution of -ΔUL20 in the somata was similar to that of the
parental HSV1(17+)Lox, but with reduced accumulation at the plasma membrane (Fig 6Div,
S3Di). After infection with -ΔUL36, -ΔUL37, or -ΔUL20, the outer tegument proteins VP22
(Fig 6Bv, 6Cv and 6Dv) and VP13/14 (Fig 7Bii, 7Cii and 7Dii) as well as gD (Fig 6Fv, 6Gv and
6Hv) and the envelope proteins gB (Fig 7Bvi, 7Cvi and 7Dvi) had still been targeted to the
axons as for the parental strain (Figs 6A, 6E and 7A), indicating that axonal transport per se
had not been impaired. Nevertheless, the deletion mutants -ΔUL36, -ΔUL37, and -ΔUL20
were incapable of efficient axonal capsid transport.
For quantitation, we scaled up two experiments to image random axonal regions and deter-
mined the number of different viral structures per axon length using a novel automated image
analysis algorithm (S4 Fig). We determined the imaged axon length, the total number of cap-
sids as detected by anti-VP26, and the fraction of these capsids colocalizing with gD or VP22
Table 2. HSV1(17+)Lox-ΔUL20 is impaired in secondary envelopment.
Cell
Type
HSV1(17+)
type
No. of cells Area [μm2] No. of
cytoplasmic capsids
No. of
capsids/area
[1/1000 μm2]
% of cytoplasmic capsids
Cytosolic Wrapping
intermediates
Enveloped
virions
Vero
cells
Lox 39 3958 269 68 48 39 13
Lox-CheVP26 39 4294 308 72 48 41 11
Lox-ΔUL20 38 4158 369 89 53 47 0
Lox-CheVP26-ΔUL20 35 4318 817 189 54 46 0
neurons Lox 28 324 48 148 27 35 37
Lox-CheVP26 31 347 92 265 46 44 10
Lox-ΔUL20 18 208 108 519 52 48 0
Lox-CheVP26-ΔUL20 19 220 58 263 47 53 0
Vero cells or DRG neurons infected with HSV1(17+)Lox, Lox-mCheVP26, Lox-ΔUL20, or Lox-CheVP26-ΔUL20 were analyzed by electron microscopy, and
the number of cytosolic capsids, wrapping intermediates and enveloped virions were determined.
https://doi.org/10.1371/journal.ppat.1006813.t002
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Fig 3. In the absence of pUL20, HSV1 capsids associate with pUL36 and pUL37. (A) Vero cells were infected with
1.1 x 107 pfu/mL (10 pfu/cell) of HSV1(17+)Lox-ΔUL36 (i), -ΔUL37 (ii) or -ΔUL20 (iii and iv). At 16 hpi, the cells were
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(c.f. S1 Table). After infection with the parental strain HSV1(17+)Lox, we counted 20 to 30
capsids per 100 μm axon length (Fig 8A; total VP26, black bars) of which 75% colocalized with
gD (Fig 8B; VP26 + gD). Furthermore, there was a similar number of membrane structures
fixed and processed for immunoelectron microscopy with antibodies against pUL36 (ii and iii) or pUL37 (i and iv). (B)
Immunogold labeling of cytoplasmic capsids was quantified after labeling with anti-pUL36 (Bi) or anti-pUL37 (Bii). The
mean values and standard errors of the mean (SEM) were calculated. P-values were calculated with the Kruskal-Wallis
test and Dunn’s multiple comparison test.
https://doi.org/10.1371/journal.ppat.1006813.g003
Fig 4. HSV1-pUL20 is not required for directed intracellular transport in epithelial cells. Vero cells were infected
with 6.4 x 106 pfu/ml (10 pfu/cell) of HSV1(17+)Lox-mCheVP26 (Ai), -ΔUL36 (Aii), -ΔUL37 (Aiii), or -ΔUL20 (Aiv) and
movies were acquired at 8–10 hpi. (A) Stills of movies in Vero cells (S1–S4 Movies) and with representative track profiles
(indicated by a colored line and the front of each track marked by an open circle). Scale bar, 5 μm. (B) Analysis of track
profiles of HSV1(17+)Lox-mCheVP26 (parental), -ΔUL36, -ΔUL37, or –ΔUL20. (Bi) Track length and (Bii) maximum step
velocity of tracks with a MSDex 1.2, (Biii) mean square displacement exponent (MSDex), with each dot representing one
track. Box and whiskers with min and max.
https://doi.org/10.1371/journal.ppat.1006813.g004
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containing gD and colocalizing with VP26 or not (Fig 8C, gD); the size of these structures var-
ied considerably (Fig 8D). After infection with Lox-ΔUL36 (Fig 8; light grey columns), or
-ΔUL20 (Fig 8; dark grey columns), there were only few capsids targeted to the axons (Fig 8A),
which again mostly co-localized with gD (Fig 8B). However, the number of gD-containing
membrane structures was only moderately reduced for the HSV-1 mutants suggesting that
axonal transport per se had not been inhibited (Fig 8C). In uninfected neurons, there was also
Fig 5. HSV1-pUL20 is not required for directed intracellular transport in neurons. DRG neurons
infected at 5 div with 1 x 107 pfu/mL of HSV1(17+)Lox-CheVP26 (Ai), -ΔUL36 (Aii), -ΔUL37 (Aiii), or -ΔUL20
(Aiv) and movies were acquired between 22 and 31 hpi. (A) Stills of movies in DRG neurons (S5–S8 Movies)
with representative track profiles (indicated by a colored line and the front of each track marked by an open
circle) of HSV1(17+)Lox-mCheVP26 (i, parental), -ΔUL36 (ii), -ΔUL37 (iii), or -ΔUL20 (iv). Scale bar, 5 μm. (B)
DRG neurons: Analysis of track profiles of HSV1(17+)Lox-mCheVP26 (parental), -ΔUL36, -ΔUL37, or -UL20.
(Bi) Track length and (Bii) maximum step velocity of tracks with a MSDex 1.2, (Biii) mean square
displacement exponent (MSDex) with each dot representing one track. Box and whiskers with min and max.
https://doi.org/10.1371/journal.ppat.1006813.g005
Axonal targeting of HSV1 particles
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006813 December 28, 2017 12 / 33
Fig 6. HSV1-pUL36, pUL37 and pUL20 are required for efficient targeting of capsids to axons. DRG neurons were infected after 3 div with 1 x 107 pfu/
mL of HSV1(17+)Lox (A and E), -ΔUL36 (B and F), -ΔUL37 (C and G), or -ΔUL20 (D and H), fixed and permeabilized using the PHEMO protocol at 26 hpi,
labeled with antibodies directed against VP26 (pAb VP26aa95-112) and VP22 (mAb 22–3, A-D) or gD (mAb DL6, E-H), and analyzed by confocal fluorescence
microscopy. (i and iv) anti-VP26, (ii and v) anti-VP22 in the upper panel and anti-gD in the lower panel, (iii and vi) anti-VP26 in green and anti-VP22 in the
upper panel and anti-gD in the lower panel in red. (i-iii) Cell bodies with nucleus and cytoplasm; (iv-vi) proximal axons. Scale bar, 5 μm.
https://doi.org/10.1371/journal.ppat.1006813.g006
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some anti-gD background signal (Fig 8C, mock), but these cross-reacting structures were
much smaller (Fig 8D). We also quantified the number of capsids detected by anti-VP26 (Fig
8E), and the fraction of these capsids colocalizing with the outer tegument protein VP22 (Fig
8F) of a parallel set of samples. After infection with the parental strain HSV1(17+)Lox, we
counted again 20 to 30 capsids per 100 μm axon length (Fig 8E; total VP26, black bars), of
which 60% to 70% colocalized with VP22 (Fig 8F; VP26 + VP22). Furthermore, there was a
similar number of structures containing VP22 colocalizing with VP26 or not (Fig 8G; VP22)
which also varied considerably in size (Fig 8H). After infection with Lox-ΔUL36, or -ΔUL20,
again fewer capsids had been targeted to the axons (Fig 8E), of which almost 80% co-localized
with VP22 (Fig 8F). The number of VP22 containing structures was moderately reduced for
the HSV-1 mutants supporting the notion that axonal transport per se had not been inhibited
(Fig 8G). In uninfected neurons, there was almost no anti-VP22 background signal (Fig 8G,
mock), and again these cross-reacting structures were much smaller (Fig 8H).
These experiments show that the inner tegument proteins pUL36 and pUL37 on the capsids
of -ΔUL20 were not sufficient for axonal targeting. Instead, association with membranes and
outer tegument proteins, and thus possibly completion of secondary envelopment seem to be a
prerequisite for efficient capsid targeting into the axons.
Discussion
Animal models as well as cultured neurons have contributed tremendously to elucidating the
mechanisms of viral neuroinvasion, spread within the nervous system, and peripheral recur-
rent diseases [1,2,23]. Various aspects of human diseases are mimicked in murine HSV-1
infection models [65]. For example, upon infection of the cornea, HSV-1 reaches the trigemi-
nal ganglia and causes herpetic keratitis; infection of the flank skin establishes latency in the
DRG, and results in zosteriform skin lesions upon reactivation [52,66–70]. To further charac-
terize alphaherpesvirus axonal targeting, we investigated here HSV infection of primary neu-
rons derived from the DRGs of adult mice, and developed novel image processing algorithms
Fig 7. HSV1 outer tegument and envelope proteins are targeted to the axon independent of capsids. DRG neurons were infected after 3 div with
1 x 107 pfu/mL of HSV1(17+)Lox-CheVP26 (A), -ΔUL36 (B), -ΔUL37 (C), or -ΔUL20 (D), fixed and permeabilized using the PHEMO protocol at 24 hpi,
labeled with antibodies directed against VP13/14 (R220, ii), gB (R69, vi) or β-III-tubulin (mAb 5564, vii) and the axons were analyzed by confocal
microscopy. CheVP26 (i and v), merge (iii and viii), differential interference contrast image (DIC, iv and ix). Scale bar is 5 μm.
https://doi.org/10.1371/journal.ppat.1006813.g007
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Fig 8. HSV1-pUL36, pUL37 and pUL20 are required for efficient targeting of capsids to axons. DRG
neurons were infected after 3 div with 1 x 107 pfu/mL of HSV1(17+)Lox, Lox-ΔUL36, Lox-ΔUL37, or Lox-
ΔUL20 (or mock treated, fixed and permeabilized using the PHEMO protocol at 24 to26 hpi, labeled with
antibodies directed against VP26 (pAb VP26aa95-112) and gD (mAb DL6, A-D) or VP22 (mAb 22–3, E-H), and
analyzed by confocal fluorescence microscopy. The images were quantified with a semi-automated algorithm.
Each bar represents the mean from one experiment, normalized to the parental values. (A-D) Labeling with
anti-VP26 and anti-gD: (A) Total number of VP26 positive structures. (B) VP26 and gD double positive
structures. (C) total gD positive structures (D) Size of gD-positive structures. (E-H) Labeling with anti-VP26
and anti-VP22: (E) Total VP26 positive structures. (F) Total number of structures labeled for VP26 and VP22.
(G) Total number of structures labeled for gD. (D) Area of structures labelled for gD. The number of capsids,
gD or VP22 structures, image numbers and total axon length are shown in S1 Table.
https://doi.org/10.1371/journal.ppat.1006813.g008
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to determine the amount of different axonal assembly intermediates in an unbiased fashion. We
infected such neurons with HSV-1 mutants that assemble cytosolic capsids lacking pUL36 and
pUL37, capsids associated only with pUL36, or capsids that recruited both, pUL36 and pUL37
to determine whether these inner tegument proteins implicated in microtubule-mediated trans-
port were sufficient for intracellular capsid motility in epithelial cells and the somata of neurons
as well as for capsid targeting to axons. Our data indicate that in addition to acquiring pUL36
and pUL37, capsids needed to complete secondary envelopment to be efficiently targeted to
axons, to spread from neurons to neighboring cells, and thus to cause recurrent diseases.
HSV infection of primary neurons derived from adult mice
Embryonic and neonatal neurons dissociated from trigeminal ganglia, DRG, or superior cervi-
cal ganglia of chicken, mouse, rat, or human have been used to study axonal trafficking and
egress of HSV particles [71–78]. However, primary cultures from embryonic tissue do not
present optimal models for age-related changes in differentiation, physiology, or late-onset dis-
ease [79–81]. We and others [82] therefore used neurons from adult mice to complement
results obtained by infecting adult animals with HSV-1 [74,83] and to obtain functional
insights into the process of axonal targeting of HSV-1 viral structures. The neurons from the
DRG of adult mice formed neurites with axonal features which contained ankyrinG and
microtubules of uniform polarity with the plus-ends pointing towards the axon endings. Fur-
thermore, we have shown previously that HSV1(17+)Lox strains that have been cloned into a
bacterial artificial chromosome and therefore lack the OriL [84,85] infect such neurons and
spread the infection to neighboring epithelial cells [52,53]. Hence murine adult DRG neurons
provide a versatile system to study productive HSV-1 infection and transport in axons with
unipolar microtubules in vivo and in vitro.
Dissection of HSV-1 axonal structures
While there is a growing consensus that the swine alphaherpesvirus PRV relies on the married
model for axonal transport in all neuron types, the picture is less clear for HSV-1. According to
the married model, capsids are enveloped exclusively in the somata, and thus it would be suffi-
cient to expose a host or a viral postal code on the cytosolic membrane surface to target vesicles
harboring fully assembled virions to axons [reviewed in 23,40,41]. But for HSV-1 two types of
axonal cargo, free cytosolic capsids as well as capsids surrounded by an envelope and a trans-
port vesicle membrane, have been detected to a varying degree [71,73,76,78,86–88].
Complementary methods have been used to image viral assembly intermediates. Antibodies
have less access to capsids associated with membranes than to cytosolic capsids [89,90]. While
fluorescent protein tags circumvent this challenge, they may shift the relative abundance of dif-
ferent assembly intermediates [57,72,73,84,91–94]. Furthermore, the resolution limit of confo-
cal microscopy is larger than a capsid diameter of 125 nm leading to an overestimation of
capsid colocalization with membrane markers. On the other hand, conventional electron
micrographs provide sufficient contrast to distinguish hexagonal capsids from membrane vesi-
cles or fully enveloped capsids within transport vesicles but only upon sufficient heavy metal
deposition and in very thin sections of 50 nm, which results in an underestimation of mem-
brane-associated capsids [47,71,87]. In embryonic rat hippocampal neurons, many cytosolic
HSV-1 capsids are indeed not associated with cytoplasmic membranes as shown by 3-dimen-
sional cryoelectron tomography [88]. The latter is in fact the best imaging method for this
question, but limited to specialized centers and not amenable to medium-throughput [95]. For
these reasons, we developed novel image quantitation algorithms and novel mutants to charac-
terize HSV-1 axonal targeting, and used both, fluorescent tagging and antibodies to detect the
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capsid protein VP26, in combination with antibodies against the tegument proteins VP22 and
VP13/14, and the envelope proteins gD and gB.
The inner tegument proteins pUL36 and pUL37 are not sufficient for
axonal targeting
The separate model of alphaherpesvirus egress postulates that different subassemblies, namely
cytosolic capsids as well as membrane vesicles conveying envelope proteins, are targeted to
axons to be assembled in the axons or just prior to trans-synaptic spread or even during budding
at the axonal plasma membrane [reviewed in 23,40,41]. Neuronal cargoes enlist the so-called
smart motors that utilize stabilized microtubules which lead to the tiny outlets to dendrites or to
axons [96,97]. One such smart motor is kinesin-1 that preferentially binds to de-tyrosinated and
acetylated microtubules, modifications that are typical for axonal microtubules while others,
such as kinesin-5 or kinesin-13 prefer tyrosinated microtubules [97,98]. Based on extensive
genetic, biochemical and cell biology experiments, pUL36 and pUL37 are considered the most
likely candidates for motor recruitment to cytosolic capsids [reviewed in 45,48]. Alphaherpes-
viruses lacking pUL36 or pUL37 are impaired in microtubule-mediated intracellular transport
[15,16,18–20,30–32,99–101]. HSV-1 capsids exposing the inner tegument proteins pUL36 and
pUL37 but not naked capsids translocate along microtubules in vitro and recruit kinesin-1 and
kinesin-2 from a brain cytosolic extract [11,43]. Finally, pUL36 of HSV-1 and PRV contains
binding sites for dynein and dynactin, and possibly the light chains of kinesin-1 [46,47].
We therefore generated HSV-1 mutants that assembled un-enveloped cytosolic capsids
with different tegument proteins. Consistent with their proposed function to recruit microtu-
bule motors, the capsids of HSV1-ΔUL20 harboring pUL36 and pUL37 but not the ones of
HSV1-ΔUL36 or HSV1-ΔUL37 were capable of active transport in epithelial cells or the
somata of DRG neurons. The capsids of HSV1-ΔUL20 therefore resemble capsids which
recruit the smart motor kinesin-1 from a cytosolic brain extract in vitro [11]. Our data indicate
that capsid-associated pUL36 and pUL37 were sufficient for microtubule transport, but not for
efficient axonal targeting.
It is possible that the capsids of HSV1-ΔUL20 had been associated with a larger amount of
outer tegument proteins covering potential motor-binding sites on the inner tegument. Capsids
with lower amounts of outer tegument recruit more kinesin-1 from a cytosolic brain extract
than capsids with more outer tegument [11]. Furthermore these outer tegument proteins might
lead to an association with cytoplasmic membranes, although our quantitative electron micros-
copy data indicate that while HSV1-ΔUL20 was impaired in completing secondary envelopment,
there was no higher association with wrapping membranes when compared to the respective
parental strains. Those capsids associated with wrapping membranes might have been con-
nected to larger membrane systems in neurons, which might have reduced their motility, and
thus their chances to find the axonal exit. Axonal transport in general had not been impaired
upon infection with either HSV-1 mutant, since the envelope proteins gB and gD as well as the
outer tegument proteins VP13/14 and VP22 had been targeted to axons. Our data are consistent
with the notion that cytosolic capsids might rely on the inner tegument for kinesin-1 mediated
transport in epithelial cells and the somata, but that transport vesicles harboring complete viri-
ons are more efficiently targeted to axons than such cytosolic capsids.
Married versus separate assembly models
Our data indicate that in addition to pUL36 and pUL37, other HSV-1 components and pro-
cesses depending on pUL20 are required for axonal targeting in adult neurons. The simplest
interpretation of our data is that HSV-1 relies also on the married model for axonal targeting
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and trafficking, and that the membrane of the transport vesicles harboring complete virions
harbors a viral or a host receptor for smart axonal microtubule motors on its cytosolic surface.
Indeed, kinesin-1 can co-traffic with PRV and HSV-1 tegument and envelope proteins [102–
104]. In the absence of pUL20, secondary envelopment was not completed, and apparently
also the tegument adopted a different conformation or composition, as our electron micros-
copy analysis revealed a different tegument contrast for capsids associated with wrapping
membranes than for complete virions. Furthermore without pUL20, the envelope proteins gD
and gH/gL, and possibly also their interaction partners VP22 and VP16 [38], are not properly
targeted to cytoplasmic virus assembly sites [105].
Of the alphaherpesvirus envelope proteins, gE/gI and pUS9 are also necessary for efficient
axonal spread but not for cytoplasmic capsid envelopment [23]. pUS9 of PRV associates with
the neuron-specific kinesin-3 subunit KIF1A, and contributes to initial axonal sorting of PRV
particles [106–108]. Similarly, pUS9 of HSV-1 is required for efficient axonal targeting, and its
large cytosolic domain interacts with the KIF5B subunit of conventional kinesin-1 [74,109]. If
the intracellular trafficking and targeting of gE/gI or pUS9 had been impaired in the absence
of pUL20, this would explain why even capsids associated with wrapping membranes could
not be targeted to the axons upon infection with HSV1-ΔUL20. According to the loading
hypothesis, capsids require in the somata in addition to the inner tegument proteins pUL36
and pUL37 also the membrane proteins gE/gI and pUS9 to be loaded onto kinesin-1
[13,109,110].
Vesicles harboring gD and possibly VP22 did neither require pUL36, pUL37 nor pUL20 for
axonal targeting. Future work elucidating which assembly intermediates of wild-type HSV-1
as well as -ΔUL36, -ΔUL37, -ΔUL20 and other deletion mutants recruit which smart microtu-
bule motors will reveal specific viral and specific host components that need to be assembled
onto an alphaherpesvirus cargo for efficient axonal targeting. Our data are consistent with the
notion that cytosolic capsids rely on the inner tegument for dynein and kinesin-1 mediated
transport prior to secondary envelopment in epithelial cells and in the neuronal somata, but
that transport vesicles harboring complete virions are more efficiently targeted to axons than
such cytosolic capsids.
Materials and methods
Cell lines
Cell lines were cultured in a humidified incubator at 37˚C and 5% CO2 and passaged twice per
week. BHK-21 cells (ATCC CCL-10) were maintained in MEM (Cytogen, Wetzlar, Germany)
supplemented with 10% (v/v) FBS (fetal bovine serum; PAA Laboratories GmbH, Co¨lbe, Ger-
many), Vero cells (ATCC CCL-81) in MEM supplemented with 7.5% (v/v) FBS, and HEK-
293T cells (ATCC CRL-11268) and Flp-In-CV-1 cells in DMEM (Invitrogen, Karlsruhe, Ger-
many) supplemented with 2 mM L-glutamine and 10% FBS (v/v). The pUL36 trans-comple-
menting Vero-derived HS30 cell line [31] was provided by Prashant Desai (Johns Hopkins
University, Baltimore, USA) and the pUL37 trans-complementing rabbit skin 80C02 cell line
[15] by Frazer J. Rixon (University of Glasgow, Scotland, UK). These complementing cells
were maintained in MEM containing 1% non-essential amino acids (Cytogen) and 7.5% or
10% (v/v) FBS, respectively. Every 5th passage was cultured in the presence of G418 (500 μg/
ml; PAA Laboratories GmbH). The trans-complementing Flp-In-CV-1-derived cell line
expressing pUL20 under the control of the HSV-1 gD promoter [54] was provided by Kon-
stantin G. Kousoulas (Louisiana State University, Louisiana, USA) and maintained in DMEM
(Invitrogen) supplemented with 10% (v/v) FBS and 2 mM L-glutamine and 125 μg/ml hygro-
mycin B (Invitrogen).
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Neurons
Primary neurons from dorsal root ganglia (DRG) of adult C57Bl/6JHanZtm mice were cultured
using established protocols [111,112]. Briefly, mice were sacrificed, and the DRG from the cervi-
cal, thoracic and lumbar level were dissected and collected in 1x HBSS-complete buffer (Hank’s
balanced salt solution, pH 7.4 with 5 mM HEPES and 10 mM D-Glucose). The DRG of three
mice were pooled and treated with 20 mg/ml papain (Sigma-Aldrich, Schnelldorf, Germany; in
0.4 mg/ml L-Cysteine, 0.5 mM EDTA, 1.5 mM CaCl2, pH 7.4) for 20 min at 37˚C, and with 10
mg/ml collagenase IV (Invitrogen) and 12 mg/ml dispase II (Sigma-Aldrich) in 1x HBSS-com-
plete buffer for 20 min at 37˚C. DRG and cells were sedimented and re-suspended in 1 ml
1xHBSS-complete buffer and triturated using Pasteur pipettes with narrowed ends. The suspen-
sions were spun for 8 min at 381 x g through 20% (v/v) Percoll (Sigma-Aldrich) cushions in
CO2-independent medium (Life Technologies Gibco, Carlsbad, CA, USA) containing 10 mM
D-glucose, 5 mM HEPES, 10% FBS, 100 U/ml penicillin and 0.1 mg/ml streptomycin. The cells
were washed with 2 ml CO2-independent medium, sedimented 2 min at 1,000 x g, suspended
in Ham’s F-12 nutrient mix medium with 10% FBS, 50 ng/ml 2.5S nerve growth factor (Pro-
mega Corporation, Fitchburg, WI, USA), 100 U/ml penicillin and 0.1 mg/ml streptomycin, and
seeded onto cover slips of 20 mm diameter in 24-well plates or glass bottom dishes (Nunc Lab-
Tek II Chambered cover glass 4-chamber #155382, #1.5 borosilicate glass, Thermo Scientific).
The cover slips and glass bottom dishes had been pre-coated with 0.01% (w/v) poly-L-lysine
(150,000–300,000 g/mol, Sigma-Aldrich) and 7 ng/μl murine laminin (Invitrogen). The cells
were cultured in a humidified incubator at 37˚C and 5% CO2, and the media were replaced
twice a week. 1-β-D-arabinofuranosylcytosine (Sigma-Aldrich) was added at 1 to 2 div to a final
concentration of 2μM to suppress proliferation of dividing, non-neuronal cells, but removed
prior to HSV-1 infection.
Antibodies
We used rabbit polyclonal antibodies (pAb) to detect VP26 [VP26aa95-112; 113], pUL36
[#147; 43], pUL37 [32], pUL20 [114], VP13/14 [R22, 115], gB [R69, 116] or VP16 (BD 3844–1,
Becton-Dickinson, Franklin Lakes, NJ, USA). Mock infected neurons showed little binding to
antisera raised against HSV-1 proteins that had been cleared by pre-adsorption [89] on unin-
fected neurons. Mouse monoclonal antibodies (mAb) were used to detect VP22 [mAb22-3;
117] or gD [mAb DL6; 118]. To detect host antigens, we used mAb 1501 for actin (Millipore,
Billerica, MA, USA), mAb 5564 for β-III-tubulin (Millipore), mAb 106/36 for ankyrinG
(E9PE32; UC Davis/NIH NeuroMab Facility), SMI-310 for phosphorylated 200 kDa and 160
kDa neurofilament (ab24570, Abcam, Cambridge, UK), and SMI-320 for non-phosphorylated
200 kDa neurofilament (ab28029, Abcam).
Viruses
We used the clinical isolate HSV1(17+) [119] and its derivatives HSV1(17+)Lox [20], HSV1
(17+)Lox-CheVP26 [20], HSV1(17+)Lox-ΔUL36 [20,47], HSV1(17+)Lox-CheVP26-ΔUL36
[20,47], HSV1(17+)Lox-ΔUL37 [20], HSV1(17+)Lox-CheVP26-ΔUL37 [20], HSV1(17+)Lox-
ΔUL20 (see below) and HSV1(17+)Lox-CheVP26-ΔUL20 (see below). Our pHSV1(17+)Lox
BAC plasmids contain a BAC cassette with a chloramphenicol resistance gene, a Cre recombi-
nase gene with an intron under the control of a eukaryotic promoter, a single flippase recogni-
tion target site (FRT) and LoxP sites at both ends inserted between the genes UL22 and UL23,
and an almost complete HSV1(17+) genome lacking only the OriL [84,85]. The Cre recombi-
nase excises the BAC cassette upon transfection into eukaryotic cells. HSV-1 stocks were pre-
pared in BHK-21, HS30 (for -ΔUL36), 80C02 (for -ΔUL37) or Flp-In-CV-1-pUL20 (for
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-ΔUL20), and extracellular virus was harvested by sedimentation from the supernatant of
infected cells as described previously [84,89,90]. After DNase treatment, the inocula of HSV1
(17+)Lox-ΔUL37 and Lox-CheVP26-ΔUL37 had genome to PFU ratios below 2,300 while that
of the other strains had genome to PFU ratios of below 108 [120].
Lentiviral production and transduction
To express EB3 in neurons, we used lentiviral transduction. The spleen focus forming virus pro-
moter was replaced by the human cytomegalovirus immediate early promoter in the plasmid
pRRL.PPT.SF.GFPpre [121, provided by Axel Schambach, Hannover Medical School, Hanno-
ver, Germany] via PCR by generating 5’PstI and 3’BamHI restriction sites adjacent to the
HCMV immediate early promoter of pCMV-Tag 2B (Agilent Technologies, Santa Clara, Cali-
fornia, USA) using the primers 5’-GAACCTGCAGCGTATTACCGCCATGCATTAGT-3’ and
5’-GAACGGATCCCCAGCTTTTGTTCCCTTTAGTG-3’. Furthermore, with the restriction
sites 5’NdeI and 3’AgeI, parts of the human cytomegalovirus immediate early promoter and EB3
were cloned from pEGFP-N-EB3 [51, provided by Marco van Ham, Helmholtz Centre for
Infection Research, Braunschweig, Germany] to generate pRRL.PPT.HCMV.GFPEB3pre. HEK
293T cells (5 x 106 per 10 cm dish) were transfected with 5 μg pRSV_Rev (provided by Axel
Schambach), 2 μg pMD2.g (Addgene Inc., Cambridge, MA, USA, Cat. No. 12259, deposited by
D. Trono, provided by Axel Schambach), 10 μg pCDNA3.GP.CCCC (provided by Axel Scham-
bach), and 10 μg transfer plasmid as described previously [122]. The supernatants were har-
vested and spun in a Beckman SW 28 rotor at 23,000 rpm or a SW32.Ti rotor at 24,000 rpm for
90 min at 4˚C (Beckman Coulter, Krefeld, Germany). The resuspended lentiviral particles were
snap frozen in liquid N2 and stored at -80˚C. For lentiviral transduction, DRG neurons were
prepared and seeded as described and at 1 div neuronal growth medium was replaced by one
containing 20 mM HEPES and the lentiviral particles.
Plaque assay
HSV-1 inocula titers were determined by plaque assays [89,90,120]. Vero, Flp-In-CV-1 or the
derivative Flp-In-CV-1-UL20-expressing cells were cultured in 6-well dishes for 16 to 20 h to
almost confluency. The respective inocula were diluted in CO2-independent medium (Life
Technologies Gibco) containing 0.1% (w/v) cell-culture grade bovine serum albumin (BSA;
Capricorn Scientific, Ebersdorfergrund, Germany), added to the cells for 1 h on a rocking plat-
form at room temperature, and then replaced by growth medium containing 20 μg/ml pooled
human IgGs (Sigma-Aldrich) to neutralize HSV-1 in the culture medium. At 3 dpi, the cells
were fixed with ice-cold, water-free methanol and air-dried prior to staining with 0.1% (w/v)
crystal violet in 2% (v/v) ethanol for 1 min. After removing the excess of crystal violet, the cells
were air-dried, and plaques were counted while using a binocular loupe (Nikon, Tokyo, Japan)
to calculate the virus titer as plaque forming units (pfu) per ml.
HSV-1 BAC mutagenesis and one-step growth curve
We used the BACs pHSV1(17+)Lox and pHSV1(17+)Lox-CheVP26 to construct HSV1(17+)
Lox-ΔUL20 and HSV1(17+)Lox-CheVP26-ΔUL20. To prevent expression of pUL20, we
mutated the ATG-start codon and a second ATG codon of UL20 to CTG followed by an
immediate insertion of 3 stop codons. Recombinant PCR fragments of pEPkan-S2 [provided
by B. Karsten Tischer and Nikolaus Osterrieder, Freie Universita¨t Berlin, Germany, 123] were
amplified to mutate the 5’ region of UL20 using traceless Red recombination, and transformed
for homologous recombination into E. coli GS1783 (provided by G. Smith, Northwestern Uni-
versity, Chicago, IL, USA) harboring pHSV1(17+)Lox or pHSV1(17+)Lox-CheVP26 [85,124].
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We used the forward primer 5’-CCTTGCGGTTTCGGTCTCCCCACCTCCACCGCACACC
CCCTGACCCTGTAGTAATAGCGGGATGACCTTCCTCTGGTTAGGGAAACAGGTAA
TCGATTT-3’, the reverse primer 5’-TCGTCGACCAGATCTCGATCACCAGAGGAAGGT
CATCCCGCTATTACTACAGGGTCAGGGGGTGTGCGGTGGCAGGTGGTGCCAGTGT
TACAACCAATTAACC-3’, the forward sequencing primer 5’-AAAGACCGGCTGGGTAT
G-3’, and the reverse sequencing primer 5’-GGGCGTAGGCGTAAATTC-3’. The mutated
start codons are underlined and the inserted stop codons are shown in bold. The BAC plas-
mids were digested with 15 U/μg DNA of AscI, BamHI, XhoI or HindIII for 3.5 h, and analyzed
on 0.6% (w/v) agarose gels in 0.5x TBE buffer (0.44 M Tris-HCl, 0.44 mM boric acid, 10 mM
EDTA, pH 8) run at 66 mA for 17 h (Peqlab system, Erlangen, Germany). To reconstitute
viruses, sub-confluent Vero or Flp-In-CV-1-UL20-expressing cells were transfected with 10 μg
BAC-DNA (MBS mammalian transfection kit; Stratagene, La Jolla, CA, USA) per 6 cm dish
and cultured until cytopathic effects had developed. Cells and medium were pooled, virus was
released by three cycles of freeze-thawing and the resulting cell pellet was used to further prop-
agate the virus according to standard protocols. The genomes of the novel HSV1(17+)Lox
strains were sequenced around the pUL20 start site that had been targeted, and the engineered
mutations were confirmed. For the growth curves, sub-confluent Vero, Flp-In-CV-1 or the
derivative Flp-In-CV-1-UL20-expressing cells were inoculated at 5 pfu/cell, the cells and the
supernatants were harvested at the indicated time points, and virus titers were determined by
plaque assay.
HSV-1 infection
Vero cells were seeded on cover slips, 3.5 cm cell culture dishes or glass-bottom chambers (Nunc
LabTek II Chambered cover glass 4-chamber #155382, #1.5 borosilicate glass, Thermo Scientific)
and infected 16 to 20 hours after the seeding as described before [16,20,29,84,89,120,125]. For syn-
chronous infections, the cells were pre-cooled for 20 min on ice, and inoculated with 10 pfu per
cell or mock treated as a control in CO2-independent medium containing 0.1% (w/v) BSA for 2 h
on ice while rocking. The cells were then shifted to regular growth medium at 37˚C and 5% CO2
for 1 h. Non-internalized virus was inactivated at 4˚C by a 3 min acid wash (40 mM citrate, 135
mM NaCl, 10 mM KCl, pH 3). Neurons cultured on cover slips in 24-well plates were pre-incu-
bated at room temperature with CO2-independent medium for 20 min, and inoculated with 1 to
5 × 106 PFU in 200 μl per well in CO2-independent medium. After 30 min, the virus-suspension
was replaced by 500 μl F-12 medium and cells were incubated again at 37˚C and 5% CO2.
Immunoblot
Cells were lysed with hot sample buffer (50 mM Tris-HCl, pH 6.8, 1% [w/v] SDS, 1% [v/v]
β-mercaptoethanol, 5% [v/v] glycerol, 0.001% [w/v] bromophenol blue) containing protease
inhibitors AEL (aprotinin, E-64, leupeptin, Sigma), ABP (antipain, bestatin, pepstatin, Sigma)
and PMSF (Roth, Karlsruhe, Germany). The proteins were separated by SDS-PAGE in 12.5%
gels and transferred in 48 mM Tris, 380 mM glycine, 0.1% [w/v] SDS and 10% [v/v] methanol
to nitrocellulose membranes (Pall Corporation, Pensacola, FL, USA). After blocking with 5%
(w/v) low-fat milk powder in PBS containing 0.1% (v/v) Tween 20, the membranes were in-
cubated with primary antibodies and secondary antibodies coupled to alkaline phosphatase
(Dianova, Hamburg, Germany), transferred to 100 mM Tris-HCl, pH 9.5, 100 mM NaCl,
5 mM MgCl2, and stained with 0.2 mM nitroblue tetrazolium chloride and 0.8 mM 5-bromo-
4-chloro-indolyl-3-phosphate. For documentation, the membranes were imaged with a digital
scanner (ScanJet 6300, Hewlett Packard, Wilmington, DE, USA).
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Fluorescence microscopy
Cells were fixed at room temperature with 3% (w/v) paraformaldehyde (PFA) in PBS for 20
min, followed by 50 mM NH4Cl for 10 min and permeabilization with 0.1% Triton-X-100 for
5 min, or at 37˚C with PHEMO fix [3.7% (w/v) PFA, 0.05% [w/v] glutaraldehyde, 0.5% [v/v]
Triton-X-100 in PHEMO buffer with 68 mM PIPES, 25 mM HEPES, pH 6.9, 15 mM EGTA,
3 mM MgCl2, 10% [v/v] dimethyl sulfoxide], washed two times with PHEMO buffer followed
by the NH4Cl treatment. The HSV-1 Fc-receptor and unspecific protein binding sites were
blocked with 10% (v/v) human serum of HSV-1-seronegative healthy volunteers and 0.5%
(w/v) BSA. Samples were labeled with primary and pre-adsorbed secondary antibodies to pre-
vent cross reactivity to antibodies of other species, namely goat-anti-mouse coupled with rho-
damine X, carbocyanine 5 or AlexaFluor488, and goat-anti-rabbit coupled with AlexaFluor488
(Invitrogen). DNA was stained using To-Pro-3-iodide or DAPI dyes (Invitrogen), and the
cover slips were mounted in Mowiol 4–88 containing 10% (w/v) 1,4-diazabicyclo-[2.2.2]
octane. The specimens were analyzed by confocal fluorescence microscopy (LSM 510 Meta,
software LSM 510 version 4, ZEISS, Go¨ttingen, Germany). Pseudo-coloring, brightness and
contrast were adjusted identically across each set of images using Adobe Photoshop CS4.
Automated image processing
To analyze systematically the degree of co-localization of tegument (anti-VP22, red channel)
or envelope proteins (anti-gD, red channel) with capsids (anti-VP26, green channel), and the
targeting efficiency of the different viral particles to the axons, we developed a novel image
processing pipeline. The semi-automated approach consists of three steps: (i) manual annota-
tion of regions of interest (ROIs) to identify the axons (cf. S4 Fig), (ii) automated particle
detection of the capsids, and (iii) automated detection of the co-localizing tegument or enve-
lope protein signal using pixel-wise image classification.
(i) ROI selection: To distinguish the axon from other structures, the regions of interest were
manually selected. To simplify the process of region annotation, a ROI is defined by position-
ing a few control points in the image and adjusting the region width at the control points, as
shown in S4 Fig. Usually, three to four control points were sufficient for accurate annotation.
(ii) Capsid particle detection: The capsids have a spherical shape with a characteristic diame-
ter. Due to blurring caused by the image acquisition process, the fluorescence signal of a single
capsid was modeled by an isotropic Gaussian distribution. Template matching was applied to
discriminate between well-separated viral particles and other signals such as background noise
or agglomerations of multiple, non-separable capsids. In detail, a detector response map Rσ(x,
y) was computed for each pixel (x, y) of the image using normalized cross-correlation of the
image signal Icapsid(x,y) with a Gaussian shaped template model Ts u; vð Þ ¼ exp   u
2þv2
2s2
 
with
variance σ2 and filter size of 1 + 2  dσ  se. Candidate particles were extracted from the detector
response map Rσ(x, y) by searching for local maxima in Rσ(x, y) using an 8-neighborhood. In
case of a plateau, a morphological shrinking operator was used to only consider the central
position of the plateau as a detection candidate. To discriminate from noise, the candidate
points pi = (xi, yi) were only accepted as capsids if the detector response Rσ(xi,yi) was greater
than a threshold τcorr and the fluorescence signal Icapsid(xi,yi) was greater than a threshold
τintens. The parameters σ, s, τcorr, and τintens were trained on manually annotated test images
using grid search. The final parameter values used throughout the experiments were σ = 0.7,
s = 1.5, τcorr = 0.4, and τintens = 0.5.
(iii) Tegument or envelope protein signal detection: We used pixel-wise image classification
in order to discriminate between signal and background noise. The classifier used various fea-
tures derived from the gD or VP22 fluorescence signals IgD(x,y): Gaussian blurred intensity
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signal IgD
s
¼ IgD  Ts, non-linearly distorted intensity EgDs;s ¼ expðs  I
gD
s
Þ normalized cross cor-
relation (NCC) of IgD to a Gaussian kernel RgDs ¼ NCCðIgD;TsÞ, and a high-pass filter clamped
to values between 0 and 1. Finally, the feature vector is
F ¼ ½RgD0:5;R
gD
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We used a logistic regression classifier which was trained on manually annotated test images.
The gD or VP22 regions were extracted from the resulting pixel-wise classification images
using a connected components analysis with an 8-neighborhood. A capsid was said to co-local-
ize with gD or VP22 if the capsid center position coincided with a gD or VP22 region dilated
by 1 pixel. The dilation operation accounted for uncertainties in both the capsid position esti-
mation and the pixel-wise gD or VP22 classification.
Several statistical parameter were derived from the automatically detected capsids and gD
or VP22 regions. The number of capsids or gD and VP22 regions per 100 μm was derived by
projecting the particle locations orthogonally to the axial center line of the ROI as illustrated in
S4 Fig.
Live cell imaging and particle tracking
For differential interference contrast imaging and to avoid evaporation at 37˚C, a glass lid was
attached to the chambers with vacuum grease (Dow Corning, Midland, Michigan, USA). Mov-
ies of infected Vero cells were recorded at 37˚ with a high temporal resolution of 5 images per
second and a pixel size of 79 nm using a confocal laser scanning microscope equipped with a
heating unit (PeCon, Erbach, Germany) as described before [20]. Movies of infected DRG neu-
rons were recorded at 37˚C (Incubator from PeCon, Erbach, Germany) with high temporal
resolution 20 images per second on a Nikon Ti microscope equipped with a Yokogawa (Ratin-
gen, Germany) CSU-X1 spinning disk and an Andor iXion Ultra 897 EMCCD camera (Belfast,
UK).
Digital movie processing
Automated tracking of cytoplasmic capsid motility was performed using the ImageJ plugin
MOSAIC [63,126]. First, the nuclei were identified by the confined nuclear capsids mobility
and the nuclear capsid fluorescence was removed. Second, the Gaussian blur filter of ImageJ
was applied (Sigma radius 2 pixel). No further image processing was performed. Third, auto-
mated tracking was performed using the Particle Tracking plugin with the following settings:
Kernel radius 3, Cutoff radius 3, percentile 0.5, displacement 20, and link range 1. Of the tracks
identified, we only considered further tracks with a length of 10 frames or longer. Track length
and maximum step velocity were calculated from tracks with a MSD exponent of 1.2 or larger,
representing non diffusive transport events.
Electron microscopy
Cells were infected as described above and fixed at the indicated time points. For conventional
electron microscopy cells were fixed with 2% glutaraldehyde in cacodylate buffer (130 mM
(CH3)2AsO2H, pH 7.4, 2 mM CaCl2, 10 mM MgCl2) for 1 h at room temperature. Cells were
washed and contrasted with 1% (w/v) OsO4 in cacodylate buffer (165 mM (CH3)2AsO2H, pH
7.4, 1.5% (w/v) K3[Fe(CH)6] followed by 0.5% (w/v) uranyl acetate in 50% (v/v) ethanol over-
night. The cells were embedded in Epon plastic (Serva, Heidelberg, Germany) and 50 nm
ultrathin sections were cut parallel to the substrate. Cytoplasmic capsids were counted and the
respective cellular areas that had been sampled were measured using an Image J plugin.
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For immunoelectron microscopy, infected cells were fixed at the indicated time points with
2% (w/v) PFA and 0.2% [w/v] glutaraldehyde, in PHEM-buffer (60 mM PIPES, 25 mM
HEPES, pH 6.9, 10 mM EGTA, 2 mM MgCl2), embedded, frozen and sectioned. Sections were
labeled using specific antibodies and protein-A gold of 10 nm (Cell Microscopy Centre,
Utrecht School of Medicine, The Netherlands). Sections were contrasted using 0.5% (w/v)
uranyl acetate in 2% methylcellulose (Merck) [127]. Images were acquired with an electron
microscope at 200 kV equipped with an Eagle 4k camera (Tecnai G2; FEI, Eindhoven, The
Netherlands). Immunogold labeling was quantified by counting each gold particle within a
radius of 100 nm around the center of a cytoplasmic capsid [20]. Data were analyzed by using
Kruskal-Wallis followed by Dunn’s post testing, and the p values were adjusted for multiple
testing (software Prism, version 6; Graphpad, San Diego, CA, USA).
Ethic statement
The mice (strain C57Bl/6JHanZtm, not genetically modified) were bred and maintained with-
out any perturbation. On the day of the experiment they were picked up from the animal facil-
ity and within 3 h sedated with CO2-inhalation prior to killing by cervical dislocation without
any prior experimental perturbation. DRG were dissected afterwards. According to the Ger-
man Animal Welfare Law §4, killing of animals does not need approval if the removal of
organs serves scientific purposes and the mice had not undergone experimental treatment
before. The animal care and sacrifice was performed in strict accordance with the German
regulations of the Society for Laboratory Animal Science (GV-SOLAS), the European Health
Law of the Federation of Laboratory Animal Science Association (FELASA) and the German
Animal Welfare Law. According to the German Animal Welfare Law, this study does not con-
tain animal experiments that require pre-approval, but the total number of killed mice was
reported at the end of each year to the animal welfare deputy of Hannover Medical School.
The number of animals killed according to §4 of the German Animal Welfare Law was regis-
tered with the animal welfare application number 2012/20 at the LAVES (Niedersaechsisches
Landesamt fuer Verbraucherschutz und Lebensmittelsicherheit, Oldenburg, Germany), and the
experiments were performed before 2013. Human sera of adult, healthy, HSV-1 seronegative
volunteers were obtained after written informed consent by the blood donors. Permission was
granted by the Institution Review Board (Hannover Medical School; Approval Number 893).
Supporting information
S1 Fig. Neurons from dorsal root ganglia of adult mice have polarized axons. DRG neurons
were cultured for 5 div, fixed using the PHEMO (A-C) or the PFA/TX-100 protocol (D) and
labeled with antibodies against β-III-tubulin (A), phosphorylated epitopes in neurofilament H
and M (B), non-phosphorylated neurofilament H (C), or ankyrinG (D). Differential interfer-
ence contrast images (i) and fluorescence (ii). Aii is one confocal slice, Bii and Cii are projec-
tions of 3 confocal slices, Dii is a projection of 7 confocal slices. Scale bars, 10 μm.
(TIF)
S2 Fig. Characterization of HSV1(17+)Lox-ΔUL20 and Lox-CheVP26-ΔUL20 mutants. (A)
Purified HSV1 BAC DNA was digested with the restriction enzymes XhoI, AscI, BamHI or Hin-
dIII, and the fragments were analyzed on agarose gels. c, bands containing the mCherry-tag;
star, bands containing the mutation. (B) Immunoblot analysis of infected cell lysates. Vero cells
were infected with HSV1(17+)Lox or its derivatives -ΔUL20, -CheVP26, or CheVP26-ΔUL20
at an MOI of 10 pfu/cell (3.2 x 107 pfu/mL), and lysed in sample buffer at the indicated time
points. The proteins were separated with a 12.5% SDS-PAGE, transferred to a nitrocellulose
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membrane, and probed with antibodies directed against pUL37, pUL20, or actin. (C) and (D)
Single step growth kinetics of parental and mutant strains, either black (squares) or tagged with
CheVP26 (circles) on either Vero cells (filled and empty symbols) or on Flp-In™-CV-1-pUL20-
complementing cells (half-filled symbols). Intracellular infectivity (C) and extracellular infectiv-
ity (D).
(TIF)
S3 Fig. HSV-1-pUL36, pUL37 and pUL20 affect the subcellular capsid distribution in the
cell body. DRG neurons were infected after 3 div with 1 x 107 pfu/mL of HSV1(17+)Lox-
CheVP26 (A), -ΔUL36 (B), -ΔUL37 (C), or -ΔUL20 (D), fixed and permeabilized using the
PHEMO protocol at 24 hpi, labeled with antibodies directed against gB (R69, ii) or β-III-tubu-
lin (mAb 5564, iii) and the cell bodies were analyzed by confocal microscopy. CheVP26 (i),
merge (v), DIC (v). Scale bar is 5 μm.
(TIF)
S4 Fig. Region of Interest annotation of the axons and computation of particles per μm. To
quantify the amount of viral structures within axons, we collected random images of axonal
regions. The schematic overview shows an example of a manual region of interest (ROI) anno-
tation (green transparent tetragons) via control points (blue) and the computation of the axon
length via orthogonal projection of the particle position (red point) on the axial centerline of
the ROI (black line). The number of structures within such an ROI was determined using a
novel automated image analysis algorithm.
(TIF)
S1 Movie. Vero cells were infected with 6.4 x 106 pfu/mL (10 pfu/cell) of HSV1(17+)Lox-
CheVP26. Live cell imaging was performed between 8 and 10 hpi using fluorescence confocal
microscopy and collecting five images per second for a total time period of 48 s. The Che chan-
nel was recorded and movie images were inverted. Individual capsids were automatically
tracked. Tracks are indicated by a colored line; the front of each track marked by an open cir-
cle. The stills of the movie and the quantification of the tracks are shown in Fig 4.
(AVI)
S2 Movie. Vero cells were infected with 6.4 x 106 pfu/mL (10 pfu/cell) of HSV1(17+)Lox-
CheVP26-ΔUL36. Live cell imaging was performed between 8 and 10 hpi using fluorescence
confocal microscopy and collecting five images per second for a total time period of 48 s. The
Che channel was recorded and movie images were inverted. Individual capsids were automati-
cally tracked. Tracks are indicated by a colored line; the front of each track marked by an open
circle. The stills of the movie and the quantification of the tracks are shown in Fig 4.
(AVI)
S3 Movie. Vero cells were infected with 6.4 x 106 pfu/mL (10 pfu/cell) of HSV1(17+)Lox-
CheVP26-ΔUL37. Live cell imaging was performed between 8 and 10 hpi using fluorescence
confocal microscopy and collecting five images per second for a total time period of 48 s. The
Che channel was recorded and movie images were inverted. Individual capsids were automati-
cally tracked. Tracks are indicated by a colored line; the front of each track marked by an open
circle. The stills of the movie and the quantification of the tracks are shown in Fig 4.
(AVI)
S4 Movie. Vero cells were infected with 6.4 x 106 pfu/mL (10 pfu/cell) of HSV1(17+)Lox-
CheVP26-ΔUL20. Live cell imaging was performed between 8 and 10 hpi using fluorescence
confocal microscopy and collecting five images per second for a total time period of 48 s. The
Che channel was recorded and movie images were inverted. Individual capsids were
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automatically tracked. Tracks are indicated by a colored line; the front of each track marked by
an open circle. The stills of the movie and the quantification of the tracks are shown in Fig 4.
(AVI)
S5 Movie. DRG neurons were infected with 1 x 107 pfu/mL with HSV1(17+)Lox-CheVP26.
Live cell imaging was performed between 22 and 31 hpi using spinning disk microscopy with
20 images per second. The Che channel was recorded and movie images were inverted. Indi-
vidual capsids were automatically tracked. The tracks are indicated by a colored line. The stills
of the movie and the quantification of the tracks are shown in Fig 5.
(AVI)
S6 Movie. DRG neurons were infected with 1 x 107 pfu/mL with HSV1(17+)Lox-CheVP26-
ΔUL36. Live cell imaging was performed between 22 and 31 hpi using spinning disk micros-
copy with 20 images per second. The Che channel was recorded and movie images were
inverted. Individual capsids were automatically tracked. The tracks are indicated by a colored
line. The stills of the movie and the quantification of the tracks are shown in Fig 5.
(AVI)
S7 Movie. DRG neurons were infected with 1 x 107 pfu/mL with HSV1(17+)Lox-CheVP26-
ΔUL37. Live cell imaging was performed between 22 and 31 hpi using spinning disk micros-
copy with 20 images per second. The Che channel was recorded and movie images were
inverted. Individual capsids were automatically tracked. The tracks are indicated by a colored
line. The stills of the movie and the quantification of the tracks are shown in Fig 5.
(AVI)
S8 Movie. DRG neurons were infected with 1 x 107 pfu/mL with HSV1(17+)Lox-CheVP26-
ΔUL20. Live cell imaging was performed between 22 and 31 hpi using spinning disk micros-
copy with 20 images per second. The Che channel was recorded and movie images were
inverted. Individual capsids were automatically tracked. The tracks are indicated by a colored
line. The stills of the movie and the quantification of the tracks are shown in Fig 5.
(AVI)
S1 Table. Quantification of HSV1 capsid axonal targeting details.
(DOCX)
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